Table 5.

Awareness of LCS, Interest in LCS, and History of Prior LCS Among Patients Eligible for LCS by 2021 USPSTF Guidelines

Cumulative (207)East Coast (33)West Coast (174)p-Value
Awareness of LCS, N (%)87 (42%)14 (42%)73 (42%)0.957
Interest in LCS, N (%)151 (73%)25 (76%)126 (72%)0.696
History of Prior LCS, N (%)57 (28%)9 (27%)48 (28%)0.972
  • Abbreviations: LCS, Lung cancer screening; USPSTF, United States Preventive Services Task Force.

  • Comparisons made using χ2 tests.